Spain's Zeltia Denies Receiving Bid For Drug Unit
Spanish biotechnology and chemicals company Zeltia strongly denied rumours of a takeover bid by a multinational company for its PharmaMar pharmaceuticals unit that sent its shares up more than 5 percent on Friday.
"Normally we do not deny rumours but in this case we roundly deny that any offer has been presented for this Zeltia unit," a company spokesman said in Madrid.
The company repeated the denial in a filing with Spain's National Securities Market Commission (CNMV).